Literature DB >> 15610674

Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity.

Obiamiwe C Umeh1, Judith S Currier.   

Abstract

In the early years of the HIV epidemic, the burden of the disease was principally among men. In recent years, HIV infection among women has become a growing problem worldwide. There is now an increasing awareness that HIV may affect men and women differently. New data have emerged from studies that have focused on HIV-infected women, suggesting the existence of sex-related differences in natural history, pharmacokinetics, and toxicity of antiretroviral therapy. This paper reviews the current literature with an emphasis on recent data regarding sex differences in HIV that have implications for clinical practice.

Entities:  

Year:  2005        PMID: 15610674     DOI: 10.1007/s11908-005-0026-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  33 in total

1.  Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study.

Authors:  C Junghans; N Low; P Chan; A Witschi; P Vernazza; M Egger
Journal:  AIDS       Date:  1999-12-24       Impact factor: 4.177

2.  Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group.

Authors:  M C Delmas; C Jadand; I De Vincenzi; C Deveau; A Persoz; A Sobel; M Kazatchkine; J B Brunet; L Meyer
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

3.  AIDS-associated Kaposi's sarcoma is more aggressive in women: a study of 54 patients.

Authors:  G Nasti; D Serraino; A Ridolfo; A Antinori; G Rizzardini; C Zeroli; L Nigro; M Tavio; E Vaccher; U Tirelli
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1999-04-01

4.  Gender differences in human immunodeficiency virus-related oral lesions: an Italian study.

Authors:  G Campisi; G Pizzo; S Mancuso; V Margiotta
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-05

Review 5.  Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women.

Authors:  Jacob Gilad; Asnat Walfisch; Abraham Borer; Francisc Schlaeffer
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-08-15       Impact factor: 2.435

6.  A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group.

Authors:  A N Phillips; F Antunes; G Stergious; A Ranki; G F Jensen; Z Bentwich; T Sacks; C Pedersen; J D Lundgren; A M Johnson
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

7.  Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

Authors:  S L Melnick; R Sherer; T A Louis; D Hillman; E M Rodriguez; C Lackman; L Capps; L S Brown; M Carlyn; J A Korvick
Journal:  JAMA       Date:  1994-12-28       Impact factor: 56.272

Review 8.  Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I.

Authors:  Marietta Anthony; Mary J Berg
Journal:  J Womens Health Gend Based Med       Date:  2002-09

9.  Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359.

Authors:  Courtney V Fletcher; Hongyu Jiang; Richard C Brundage; Edward P Acosta; Richard Haubrich; David Katzenstein; Roy M Gulick
Journal:  J Infect Dis       Date:  2004-03-16       Impact factor: 5.226

10.  Heterosexual transmission of HIV--29 states, 1999-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-02-20       Impact factor: 17.586

View more
  3 in total

1.  Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.

Authors:  C Bazzoli; H Bénech; E Rey; S Retout; D Salmon; X Duval; J M Tréluyer; F Mentré
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

Review 2.  Cardiovascular disease risk among women living with HIV in North America and Europe.

Authors:  Lauren Stone; Sara E Looby; Markella V Zanni
Journal:  Curr Opin HIV AIDS       Date:  2017-11       Impact factor: 4.283

3.  Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis.

Authors:  Cassidy W Claassen; Marie Diener-West; Shruti H Mehta; David L Thomas; Gregory D Kirk
Journal:  Clin Infect Dis       Date:  2012-03-28       Impact factor: 9.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.